Literature DB >> 23740619

Short-term weight loss patterns, baseline predictors, and longer-term follow-up within a randomized controlled trial.

Veronica Yank1, Lan Xiao, Sandra R Wilson, Randall S Stafford, Lisa Goldman Rosas, Jun Ma.   

Abstract

OBJECTIVE: To examine weight loss patterns and predictors among participants in a primary care-based translation study of the Diabetes Prevention Program lifestyle intervention. DESIGN AND METHODS: Cluster analysis identified short-term (12-week) weight loss patterns among 72 intervention participants. Analysis of variance assessed cluster differences in weight loss maintenance at 15-month follow-up. Discriminant analysis identified baseline characteristics that best differentiated between clusters.
RESULTS: Participants had baseline mean (SD) age of 55.0 (10.8) years and BMI of 31.9 (5.2) kg/m(2) . Cluster analysis identified three short-term weight loss patterns: modest (n = 15; 21%), moderate-and-steady (n = 43; 60%), and substantial-and-early (n = 14; 19%). Only participants with the latter two patterns achieved clinically significant (≥5%) short-term weight loss and maintained it at 15 months. On discriminant analysis, the modest cluster was most differentiated from other clusters by high friend encouragement for dietary change, high obesity-related problems, and low physical well-being. The moderate-and-steady cluster was differentiated by lower physical activity, family encouragement, and depression symptoms.
CONCLUSION: Results provided insight into the heterogeneity of response to an effective lifestyle intervention by identifying short-term weight loss patterns and their baseline predictors and relationship to 15-month success. If replicated, results may help tailor strategies for participant subgroups in weight loss programs.
© 2013 The Obesity Society.

Entities:  

Mesh:

Year:  2013        PMID: 23740619      PMCID: PMC3815705          DOI: 10.1002/oby.20510

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


INTRODUCTION

Two thirds of American adults are overweight or obese (1). Losing as little as 5% of baseline weight is clinically significant (2–8). Most weight loss trials, including those with lifestyle interventions, evaluate weight change at only a few time points, typically 6 or more months apart, and focus on cumulative weight lost at trial conclusion (2, 4, 9, 10). By that time, some participants have achieved a 5% weight loss goal, others have not, and even others have achieved substantially greater weight loss. While prior studies have examined weight loss patterns of participants using several weight measurements over time, the time interval between measurements has been months to years (11–14). We have been unable to identify prior lifestyle intervention studies describing short-term weigh loss patterns derived from weights measured over weekly intervals, their relation to longer-term weight loss maintenance, and baseline predictors of the patterns. Thus, little is known about participants’ week-to-week weight change patterns early in trials and how these might relate to longer-term weight loss achievement (or lack thereof). In response to the well-recognized heterogeneity of weight loss outcomes (13–15), others have called for research on intervention tailoring (15, 16) to better optimize weight loss outcomes for all. Cluster analysis can contribute to this literature, because it has the potential to identify distinct subgroups of individuals who cluster according to week-to-week short-term weight loss trajectories. The identified clusters then can be compared for differences in baseline variables (e.g., socio-demographic, clinical, and psychosocial measures) and also according to their longer-term weight loss success. If a short-term weight loss pattern is identified as predictive of poor long-term weight loss, individuals within such a cluster might be targeted for early, tailored strategies to improve their chances of achieving weight loss goals. Individuals in clusters associated with better success might receive different tailoring, e.g. reinforcement or other strategies to support continued weight loss momentum. Given these potential benefits, we assessed short-term weight loss patterns among intervention participants in a primary care-based translation (17, 18) of the Diabetes Prevention Program (DPP) lifestyle intervention (2). Specifically, our study objectives were to determine (a) whether we could identify patterns of individual week-to-week weight change trajectories over the initial 12-week intensive intervention period; (b) if so, whether baseline characteristics predicted these patterns; and (c) whether participants with differing short-term weight change patterns also differed in weight loss outcomes over the remainder of the 15-month trial. We hypothesized that cluster analysis would identify distinct weight loss patterns.

METHODS AND PROCEDURES

Evaluation of Lifestyle Interventions to Treat Elevated Cardiometabolic Risk in Primary Care (ELITE) was a 3-arm randomized controlled trial whose design and primary outcomes have been published (17, 18). The trial demonstrated the effectiveness of two DPP-based lifestyle interventions translated into primary care among 241 overweight/obese adults with pre-diabetes, metabolic syndrome, or both, but not known cardiovascular disease. Trial participants were randomly assigned to usual care (n=81) or one of two active interventions: self-directed DVD intervention (n=81) or coach-led group intervention (n=79); the latter group is the focus of the current study. During the initial intensive phase of the trial, coach-led participants had private weigh-ins before the start of each of 12 weekly group sessions. Weight was measured once by a lifestyle coach on a digital scale. To accurately estimate individual 12-week weight change trajectories, we included only the 72 of 79 participants who had weights measured at ≥4 group sessions. These participants attended a median of 10 group sessions (interquartile range [IQR] 9–11). The seven excluded participants were similar to those included on baseline characteristics (3 of 7 female, baseline mean body mass index (BMI) 30.0 (SD 3.7)) and percent weight loss at trial completion (5.3% (SD 8.6)). We computed weekly weight change as a percentage of the weight measured at group session 1 or, for the four participants who missed session 1, as a percentage of the weight measured at the baseline study visit, all of which occurred within the per-protocol limit of 21 days before session 1. Research staff blinded to treatment assignment conducted study visits (separate from group sessions) at baseline and months 3, 6, and 15. They measured weights in duplicate on a different scale (calibrated balance beam) from the group session scale. Seventy-one (99%) of 72 participants attended the 3-month visit, 66 (92%) the 6-month visit, and 62 (86%) the 15-month visit. We obtained clinically-measured weights from the electronic health record or patient self-report for 3 of 6 participants who did not attend the 6-month visit and 7 of 10 who did not attend the 15-month visit. Thus, follow-up weight data were available for 71 (99%) participants at 3 months, 69 (96%) at 6 months, and 69 (96%) at 15 months. Measured baseline characteristics (17) included socio-demographics (age, sex, race/ethnicity, education, income), clinical measures (BMI, pre-diabetes [fasting plasma glucose 100–125 mg/dL] status, metabolic syndrome [defined by modified Adult Treatment Panel III criteria (19)] status, blood pressure, fasting glucose, triglycerides, high density lipoprotein cholesterol, low density lipoprotein cholesterol), caloric and fat gram intake, leisure time physical activity as metabolic equivalent of task (MET) minutes/week (20), and psychosocial measures: physical and mental well-being (sub-scales of the 12-Item Short-Form Health Survey [SF-12]) (21), obesity-related problems (22), self-efficacy (23) and social support (24) for diet and exercise behaviors, depression symptoms (depression module of the Patient Health Questionnaire [PHQ-9]) (25), and body size dissatisfaction (26).

Statistical analysis

Individual trajectories of week-to-week weight change over the initial 12-week period were estimated using a polynomial regression function with a constrained intercept of no change. Percent weight change was modeled as the dependent variable, and both linear and quadratic terms for time in weeks were independent variables. We chose the best fit for the data based on the significance of polynomial terms. Parameter estimates for linear and quadratic terms describing individual weight change trajectories were then classified into similar patterns based on disjoint cluster analysis using a k-means model and SAS FASTCLUS procedure (27). We sequentially applied the FASTCLUS procedure using different numbers of clusters (range 2–5). We used the Cubic Clustering Criterion (CCC) and visual assessment of clusters to identify the optimal cluster number. Absolute CCC values ≥ 2 indicate good clusters, while CCC values <2 or “clusters” that contain only 1–4 individuals (outliers) are suboptimal. After identifying the optimal cluster number, we examined differences in baseline characteristics between clusters using analysis of variance (ANOVA) for continuous variables and Chi-square test for categorical variables. Characteristics with p<0.1 were considered candidate predictor variables for further evaluation. We next calculated Pearson correlation coefficients to assess the strength of associations among continuous candidate variables. Then, we applied discriminant analysis to identify “dimensions” (linear combinations of candidate variables) that best differentiated between clusters (28). Finally, we evaluated persistence of initial 12-week weight loss over time by using ANOVA to compare cluster weight changes at 3-, 6-, and 15-month study visit assessments as a percentage of baseline visit weight. Because these measurements were taken by blinded research staff on a different scale and day, 3-month study visit weights were considered independent validation of weights measured at the end of the 12-week group sessions. All analyses were conducted in SAS version 9.2 (SAS Institute Inc., Cary, North Carolina). P values are two-tailed with statistical significance defined as P<0.05.

RESULTS

Baseline Characteristics

The 72 participants had a baseline mean (SD) age of 55.0 (10.8) years, 49% were female, 79% were non-Hispanic White, 14% were Asian, and 97% were college educated. Baseline mean (SD) BMI was 31.9 (5.2) kg/m2, 56% had pre-diabetes, and 90% had metabolic syndrome.

Short-Term (12-week) Weight Loss Patterns

Cluster Analysis

Because the 2-cluster analysis achieved a CCC of only −1.69, and the 4-cluster and 5-cluster analyses identified clusters containing only 1–4 individuals, these analyses were rejected. The 3-cluster analysis achieved a CCC of −5.19 and clusters with ≥14 individuals, so was chosen as the optimal analysis. The polynomial regression model with quadratic terms for assessing individual week-to-week weight change trajectories fit the data significantly better than one without quadratic terms (χ2=23.22, p<0.0001). Therefore, both linear and quadratic terms were used to describe individual weight trajectories and were included in the cluster analysis. Cluster analysis identified three short-term weight change patterns: “modest” (n=15; 20.8%) with the least amount of weight loss over 12 weeks, “moderate-and-steady” (n=43; 59.7%) with the middle amount of weight loss, and “substantial-and-early” with the most total weight loss and highest proportion of that being achieved during the early weeks compared to later weeks (n=14; 19.4%) (Figure 1). The linear term (β1) was significant for all clusters, while the quadratic term (β2) was significant only for the moderate-and-steady and substantial-and-early clusters. Only the moderate-and-steady and substantial-and-early clusters achieved clinically significant (≥ 5%) weight loss by session 12 (–6.9% [95% confidence interval (CI) –9.7%, –4.2%] and –8.8% [–12.5%, –5.1%], respectively), whereas the modest cluster did not (–4.0% [–8.0%, 0.1%]). These results were consistent with weight measurements taken by blinded research staff at 3-month study visits (Figure 2) (note that percent weight loss estimates for session 12 in Figure 1 fall within the CIs for 3-month measurements in Figure 2). The mean number of group sessions attended during the initial 12 weeks was high for all clusters—modest 8.6 (72%) sessions, moderate-and-steady 10.3 (86%), substantial-and-early 9.6 (80%)—but differed significantly between the modest and moderate-and-steady clusters (p=0.001). Other comparisons were not significant (p=0.11 for modest vs. substantial-and-early, p=0.19 for moderate-and-steady vs. substantial-and-early).
Figure 1

Short-Term Weight Loss Patterns During Initial 12 Weeks

R2 values for short-term weight loss patterns, with and without quadratic terms: modest, 0.51, 0.50; moderate-and-steady, 0.91, 0.91; and substantial-and-early, 0.92, 0.91.

Figure 2

Between-Cluster Differences in Weight Loss at Follow-Up Time Points

Comparisons between clusters: at 3 months, modest vs. moderate-and-steady (p=0.03), modest vs. substantial-and-early (p=0.04), moderate-and-steady vs. substantial-and-early (p=0.70); at 6 months, modest vs. moderate-and-steady (p=0.004), modest vs. substantial-and-early (p=0.001), moderate-and-steady vs. substantial-and-early (p=0.21);and at 15 months, modest vs. moderate-and-steady (p=0.008), modest vs. substantial-and-early (p=0.007), moderate-and-steady vs. substantial-and-early (p=0.53).

Bivariate Analysis

Eight baseline characteristics were identified as candidate predictor variables: sex, physical activity, and scores on scales measuring physical well-being, family and friend encouragement for dietary change, obesity-related problems, depression symptoms, and body size dissatisfaction (Table 1). Obesity-related problems was the variable with highest number of significant correlations—with greater family or friend encouragement for dietary change, depressive symptoms, and body size dissatisfaction (Table 2).
Table 1

Baseline Characteristics of Participants by Weight Change Pattern Group

Weight change pattern group
Baseline characteristicsAlln=72Group 1Modestn=15Group 2Moderate & steadyn=43Group 3Substantial & earlyn=14P-value
Age55.0 ± 10.852.1 ± 12.656.4 ± 10.453.9 ± 10.00.394
Female, %48.66053.521.40.067*
BMI, kg/m2, men30.6 ± 3.732.7 ± 3.330.7 ± 4.129.2 ± 2.60.160
BMI, kg/m2, women33.4 ± 6.234.4 ± 6.133.2 ± 6.432.8 ± 6.50.876
Leisure-time physical activity, MET min/week1235.7 ± 1283.71197.7 ± 1008.71064.3 ± 936.01992.86 ± 1700.20.033*
Physical well-being (range 0–100)47.1 ± 7.443.1 ± 9.247.9 ± 7.048.9 ± 5.20.059*
Obesity-related problems (range 0–3)1.4 ± 0.81.9 ± 0.81.4 ± 0.81.1 ± 0.80.025*
Family encouragement for dietary change (range 7–35)13.6 ± 6.216.1 ± 6.612.2 ± 5.415.1 ± 7.00.061*
Friend encouragement for dietary change (range 7–35)10.1 ± 3.612.0 ± 4.110.0 ± 3.88.4 ± 2.60.068*
Depression symptoms (range 0–27)3.5 ± 3.95.7 ± 5.82.8 ± 3.13.4 ± 3.20.049*
Body size dissatisfaction (range −8–8)2.3 ± 0.82.8 ± 1.02.2 ± 0.72.1 ± 0.60.020*

BMI=body mass index. Leisure time physical activity as metabolic equivalent of task (MET) minutes/week was calculated from the Stanford 7day Physical Activity Recall (20). Physical well-being was calculated from the physical sub-scales of the 12-Item Short-Form Health Survey [SF-12] (21). Obesity-related problems was determined from the obesity-related problem scale (25). Social support for diet and exercise behaviors was determined from pertinent scales (24). Depression symptoms were measured with the depression module of the Patient Health Questionnaire [PHQ-9]) (25), Body size dissatisfaction was measured with the Body Image Assessment [BIA] scale (26). Other baseline characteristics that were assessed (as described in the Methods) but are not shown here, due to space constraints, did not significantly differ (p<0.1) by weight change pattern group, and included: race/ethnicity, education, income, pre-diabetes status, metabolic syndrome status, waist circumference, blood pressure, fasting glucose, triglycerides, high density lipoprotein cholesterol, low density lipoprotein cholesterol, ratio of triglycerides to high density lipoprotein cholesterol, caloric and fat gram intake, mental well-being, self-efficacy, and social support for exercise behaviors.

Characteristics with p<0.1 were considered candidate predictor variables for further analysis (i.e., calculation of the Pearson correlation coefficient for continuous candidate predictor variables and discriminant analysis for all candidate predictor variables).

Table 2

Pearson Correlation Coefficients between Candidate Predictor Variables

Obesity-relatedproblemsFamilyencouragementfor dietarychangeFriendencouragementfor dietarychangeDepressionsymptomsBody sizedissatisfactionPhysical well-beingPhysicalactivity
Obesity-related problems1
Family encouragement for dietary change0.28 (0.02)1
Friend encouragement for dietary change0.32 (0.01)0.21 (0.08)1
Depression symptoms0.50 (<.0001)0.08 (0.51)0.22 (0.07)1
Body size dissatisfaction0.36 (0.002)0.11 (0.37)0.45 (<.0001)0.25 (0.04)1
Physical well-being−0.2 (0.09)−0.21 (0.07)−0.12 (0.31)−0.24 (0.05)−0.32 (0.01)1
Physical activity−0.15 (0.20)0.01 (0.90)0.09 (0.43)−0.09 (0.46)−0.13 (0.27)0.09 (0.44)1

Discriminant Analysis

Discriminant analysis identified two statistically significant combinations of the eight candidate variables–i.e., dimensions–that differentiated between weight loss patterns, with Dimension 1 differentiating more between clusters than Dimension 2 (Table 3 and Figure 3). On Dimension 1, baseline characteristics with standardized canonical coefficients of greatest magnitude were friend encouragement for dietary change (0.66), obesity-related problems (0.53), physical activity (–0.41), and physical well-being (–0.40). On Dimension 2, characteristics with the coefficients of greatest magnitude were physical activity (0.58), family encouragement for dietary change (0.57), depression symptoms (0.54), and body size dissatisfaction (0.40).
Table 3

Discriminant Analysis Separating the Three Weight Change Clusters

Pooled Within-Class Standardized Canonical Coefficients

VariableDimension 1Dimension 2
Female0.03−0.23
Obesity-related problem0.53−0.05
Family encouragement for dietary change−0.220.57
Friend encouragement for dietary change0.66−0.20
Depression symptoms−0.130.54
Body size dissatisfaction−0.080.40
Physical well-being−0.40−0.11
Physical activity−0.410.58

Dimension 1 (canonical function F(16,118)=2.35, p=0.005; canonical correlation=0.52) differentiates more between weight loss clusters than does Dimension 2 (canonical function F(7,60)=2.34, p=0.035; canonical correlation=0.46.

Figure 3

Canonical Scores on Dimensions 1 and 2

Each ellipse indicates an 80% confidence ellipse for the mean of each cluster, which is in the center of the ellipse. Ellipses 1, 2, and 3 correspond to the modest, moderate-and-steady, and substantial-and-early clusters, respectively. Each dot represents an individual participant. Individual dots (participants) of one color belong to the ellipse (cluster) of the same color.

Qualitative Interpretation of Discriminant Analysis

The modest weight loss cluster had the highest score on Dimension 1 (Figure 3), findings driven by having the highest levels of friend encouragement and obesity related problems and lowest levels of physical well-being (Table 1). Among clusters with clinically significant weight loss, the moderate-and-steady cluster had the lowest score on Dimension 2 (Figure 3), driven by its lowest levels of baseline physical activity, family encouragement, and depression symptoms and second-lowest level of body size dissatisfaction (Table 1). The substantial-and-early cluster had the lowest mean score on Dimension 1 (Figure 3), in contrast to the modest cluster’s high score, and is differentiated most prominently from the moderate-and-steady cluster on Dimension 2 by much higher levels of baseline physical activity (Table 1).

Persistence of Weight Loss Patterns During 15-Month Follow-Up Period

When clusters were followed for the remainder of the trial (Figure 2), the moderate-and-steady and substantial-and-early had lowest weights at 6-month follow-up and maintained clinically important mean weight loss (≥ 5% of baseline weight) through the 15-month close of the trial. The modest cluster did not achieve clinically important weight loss at any time point. There were significant weight loss differences between the modest cluster and others at all time points but no differences between the moderate-and-steady and substantial-and-early clusters (Figure 2).

DISCUSSION

Cluster analysis identified three distinct 12-week weight loss patterns among intervention participants in a DPP-based lifestyle intervention trial. The two clusters that achieved clinically significant short-term weight loss were also the only ones that achieved and maintained significant weight loss at 15-month follow-up. Discriminant analysis identified two significant dimensions that distinguished between clusters, with baseline characteristics regarding social support, obesity-related problems, depression symptoms, body size dissatisfaction, physical well-being, and physical activity having greatest influence. On Dimension 1 participants with the lowest weight loss (modest cluster) reported the highest baseline level of friend encouragement for dietary change. Kiernan et. al. noted similar findings in their behavioral weigh loss trial (29) and had qualitative data that might explain this finding. Their participants stated that reminders from friends regarding healthy habits “only make me feel worse.” Thus, friend “encouragement” captured on our Dimension 1 may have been experienced by participants as negative reminders rather than positive support. Participants in the modest cluster also had the most extreme levels on other Dimension 1 characteristics— highest level of obesity-related problems and lowest level of physical well-being. If replicated, these results emphasize the importance of identifying participants similar to our modest cluster who might benefit from tailored interventions to target these psychosocial characteristics. Dimension 2 was differentiated by baseline physical activity level and psychosocial characteristics—family encouragement for dietary change, depression symptoms, and body size dissatisfaction. The moderate-and-steady cluster had the lowest scores on most of these. Its comparatively low score on baseline physical activity suggests a potential capacity for increased exercise. Its low score on family encouragement, as with the findings above regarding friend encouragement and the study by Kiernan et. al. (29), may suggest a deficiency in the instrument we used to measure social support (24). The instrument does not capture the patient experience, whether negative, positive, or neutral, of the types of “social support” itemized in its questions. Thus, it remains speculative as to why the moderate-and-steady cluster experienced weight loss success in the setting of low baseline family support. Finally, the cluster’s lower scores regarding depression symptoms and body size dissatisfaction may indicate low psychosocial baseline barriers in these domains (15,30). If these results are replicated, participants with similar baseline characteristics might benefit from intervention tailoring that expands on exercise-related skills-building and positive social support. The substantial-and-early cluster scored the lowest on Dimension 1 and high on Dimension 2, driven by its relative psychosocial stability on multiple measures and high physical performance. The cluster reported baseline physical activity levels almost twice that of other clusters (Table 1) and three times the minimum recommended by U.S. national guidelines (~600 MET minutes/week) (31). If replicated, results for the substantial-and-early cluster highlight the importance of tailoring intervention components to participants who have already mastered certain skills, so that they can be targeted for enhancements or skills-building in areas not yet mastered. Prior studies have examined weight change patterns over time. However, they included longer time intervals between measurements than the 1-week increments in the current study, making comparisons difficult. The Look AHEAD trial group assessed 1-month interval weight data from the first trial year, but in contrast to our findings found no evidence of distinct weight loss clusters (11). In another paper, the same trial group found that certain patterns of weight loss over the first trial year, specifically greater month-to-month weight loss and more gradual and sustained weight loss, were each associated with greater weight loss by trial year four (12). Kumanyika et al. examined weight change patterns over three month increments among the elderly and identified patterns of less weight regain among blacks compared to whites (13). Other studies have assessed whether baseline characteristics are predictive of final weight loss at trial completion. For most of the eight baseline predictors we identified as best differentiating between weight loss clusters, others have had similar results. We have already noted overlap between findings on social support and those of Kiernan et. al. (29). Our findings regarding other psychosocial characteristics also generally align with those of others. Teixeira et. al. reviewed the literature on psychosocial predictors of weight loss in trials targeting lifestyle modification (15). They concluded that higher body size dissatisfaction and lower obesity-related quality of life were associated with less successful weight loss. However, among behavioral weight loss trials published since the Teixeira review, Annesi et. al. found that higher baseline body size dissatisfaction was associated with more successful weight loss (30). Their trial included younger and all-female participants (mean age 44.2 years (SD 9.2)) and 52% white and 41% African American participants versus the current study’s composition. Regarding depression symptoms and weight loss, the literature is mixed. While a recent meta-analysis of population-based cross-sectional studies identified a significant positive association between obesity and depression among women, it did not identify one among men (32). In the trial literature, the Teixeira et. al. review concluded that depression was not an important predictor of weight loss. Among trials published more recently, Wolf et. al. reported that overweight male veterans with knee osteoarthritis who had higher levels of depression achieved lower weight loss (33), whereas Ludman et. al. found no difference in weight loss outcomes among women with and without major depression (34). While it is known that physical activity is an important predictor of weight maintenance (35), there is less evidence on baseline physical activity level as a predictor of outcomes in weight loss trials. In the DPP, baseline physical activity level was not associated with diabetes outcome (36), although the mean reported baseline level of physical activity (930 MET min/wk) (2) was lower than that (1236) in the current study. Among behavioral weight loss intervention studies that have included both men and women, most have not examined differences in outcome by sex (37), likely because they may not powered to do so—as is the current study. Those studies that have had adequate enrollment to evaluate outcomes by sex have generally found that men achieve greater weight loss than women (14). While our discriminant analyses identified sex as a contributor to both Dimensions 1 and 2, its canonical coefficients were low. Our analyses did not identify race/ethnicity as a factor distinguishing between clusters, but our sample size for sub-groups was low. Others have identified race as being associated with weight loss outcomes. Finally, studies have examined adherence factors as predictors of longer-term weight loss and found them to be significant (38). The time frame and high attendance rates (72%–86%) in the current study are not directly comparable to the longer time frames and lower attendance rates (~54%) observed in other studies (38). Others have called for research on intervention tailoring to narrow the gap in weight loss outcomes among subgroups (15, 16). The current study extends this literature by identifying baseline characteristics that distinguish between short-term weight loss patterns that are, in turn, predictive of achievement (or lack of achievement) of clinically significant weight loss by 15-month follow-up. While these findings are exploratory, they suggest intriguing avenues for investigation on tailoring intervention components to important patient subgroups. If our findings are replicated and elaborated upon, professionals who deliver behavioral weight loss programs might use them for early identification of participant subgroups who are less likely to achieve their weight loss goals and for quickly tailoring interventions to them. But additional questions remain: what augmentation strategies would most effectively boost responsiveness during the early intervention stage, do these participants need an extended intensive intervention phase, or do they instead need a switch strategy—that is, to abort the initial treatment altogether and instead adopt an entirely new program? Weight loss professionals might also identify participant subgroups likely to experience early weight loss success. For these, program leaders also might appropriately adopt differently tailored materials. After further analysis and development, subgroup behavioral tailoring based on baseline characteristics and short-term weight loss patterns therefore might enable more efficient and effective deployment of scarce weight loss resources. There are several limitations to our findings. First, because of the small sample size and post hoc nature of the analyses our findings are exploratory and should be interpreted with caution. Second, our population included highly educated participants primarily of White or Asian racial background, although with a good mix of men and women. Third, while we analyzed baseline characteristics suggested to be important by the literature at the time of trial initiation, we did not examine other baseline characteristics (e.g., personality traits) (39, 40) that more recent studies have assessed. Fourth, the social support scale (24) may have inherent limitations in that the activities it measures may sometimes be experienced by respondents as undermining rather than supportive. Finally, the literature suggests that weight regain may occur past the 15-month follow-up of the current study (6); nonetheless, 15 months is a longer follow-up period than is found in many weight loss trials. In conclusion, we have identified short-term weight loss patterns and baseline psychosocial and physical activity characteristics that were predictive of these among overweight and obese adult participants in an evidence-based group lifestyle intervention. Short-term achievement (or lack of achievement) of clinically significant weight loss was predictive of successful weight loss at 15-month follow-up. If these results are replicated and expanded upon in other studies, they may identify subgroups of participants to be targeted for specific, tailored support that will better enable their weight loss success.
  34 in total

1.  Screening for obesity in adults: recommendations and rationale.

Authors: 
Journal:  Ann Intern Med       Date:  2003-12-02       Impact factor: 25.391

Review 2.  Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Authors: 
Journal:  Obes Res       Date:  1998-09

3.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.

Authors:  J Ware; M Kosinski; S D Keller
Journal:  Med Care       Date:  1996-03       Impact factor: 2.983

4.  The development of scales to measure social support for diet and exercise behaviors.

Authors:  J F Sallis; R M Grossman; R B Pinski; T L Patterson; P R Nader
Journal:  Prev Med       Date:  1987-11       Impact factor: 4.018

5.  Psychosocial functioning in the obese before and after weight reduction: construct validity and responsiveness of the Obesity-related Problems scale.

Authors:  J Karlsson; C Taft; L Sjöström; J S Torgerson; M Sullivan
Journal:  Int J Obes Relat Metab Disord       Date:  2003-05

6.  Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial.

Authors:  Lawrence J Appel; Catherine M Champagne; David W Harsha; Lawton S Cooper; Eva Obarzanek; Patricia J Elmer; Victor J Stevens; William M Vollmer; Pao-Hwa Lin; Laura P Svetkey; Sarah W Stedman; Deborah R Young
Journal:  JAMA       Date:  2003 Apr 23-30       Impact factor: 56.272

7.  Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

Authors:  J Tuomilehto; J Lindström; J G Eriksson; T T Valle; H Hämäläinen; P Ilanne-Parikka; S Keinänen-Kiukaanniemi; M Laakso; A Louheranta; M Rastas; V Salminen; M Uusitupa
Journal:  N Engl J Med       Date:  2001-05-03       Impact factor: 91.245

8.  Ethnic comparison of weight loss in the Trial of Nonpharmacologic Interventions in the Elderly.

Authors:  Shiriki K Kumanyika; Mark A Espeland; Judy L Bahnson; Juliene B Bottom; Jeanne B Charleston; Steve Folmar; Alan C Wilson; Paul K Whelton
Journal:  Obes Res       Date:  2002-02

9.  Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin.

Authors:  William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan
Journal:  N Engl J Med       Date:  2002-02-07       Impact factor: 91.245

Review 10.  Behavioral, psychological, and environmental predictors of obesity and success at weight reduction.

Authors:  K D Brownell
Journal:  Int J Obes       Date:  1984
View more
  16 in total

1.  The role of social support in weight loss maintenance: results from the MedWeight study.

Authors:  Eleni Karfopoulou; Costas A Anastasiou; Evangelia Avgeraki; Mary H Kosmidis; Mary Yannakoulia
Journal:  J Behav Med       Date:  2016-01-22

2.  Longitudinal Weight Outcomes From a Behavioral Lifestyle Intervention in Clinical Practice.

Authors:  Robert J Romanelli; Hsiao-Ching Huang; Vidita Chopra; Jun Ma; Elizabeth M Venditti; Sylvia Sudat; Deborah A Greenwood; Alice R Pressman; Kristen M J Azar
Journal:  Diabetes Educ       Date:  2019-09-03       Impact factor: 2.140

3.  Longitudinal Weight Loss Patterns and their Behavioral and Demographic Associations.

Authors:  Amanda N Szabo-Reed; Jaehoon Lee; Lauren Ptomey; Erik Willis; Matt Schubert; Richard Washburn; Joseph E Donnelly
Journal:  Ann Behav Med       Date:  2016-02

Review 4.  Depression and obesity among females, are sex specificities considered?

Authors:  Ingrid Baldini; Breno P Casagrande; Debora Estadella
Journal:  Arch Womens Ment Health       Date:  2021-04-20       Impact factor: 3.633

5.  Effect of an Intervention for Obesity and Depression on Patient-Centered Outcomes: An RCT.

Authors:  Lisa G Rosas; Kristen M J Azar; Nan Lv; Lan Xiao; Jeremy D Goldhaber-Fiebert; Mark B Snowden; Elizabeth M Venditti; Megan M Lewis; Andrea N Goldstein-Piekarski; Jun Ma
Journal:  Am J Prev Med       Date:  2020-02-14       Impact factor: 5.043

6.  Early-treatment weight loss predicts 6-month weight loss in women with obesity and depression: implications for stepped care.

Authors:  Molly E Waring; Kristin L Schneider; Bradley M Appelhans; Andrew M Busch; Matthew C Whited; Stephanie Rodrigues; Stephenie C Lemon; Sherry L Pagoto
Journal:  J Psychosom Res       Date:  2014-03-25       Impact factor: 3.006

7.  Predictors of Long-Term Adherence to Multiple Health Behavior Recommendations for Weight Management.

Authors:  Stephanie L Fitzpatrick; Lawrence J Appel; Bethany Bray; Neon Brooks; Victor J Stevens
Journal:  Health Educ Behav       Date:  2018-02-24

8.  Weight Loss Trajectories and Related Factors in a 16-Week Mobile Obesity Intervention Program: Retrospective Observational Study.

Authors:  Ho Heon Kim; Youngin Kim; Andreas Michaelides; Yu Rang Park
Journal:  J Med Internet Res       Date:  2022-04-15       Impact factor: 7.076

9.  Sex Moderates Treatment Effects of Integrated Collaborative Care for Comorbid Obesity and Depression: The RAINBOW RCT.

Authors:  Nan Lv; Lan Xiao; Lisa G Rosas; Elizabeth M Venditti; Joshua M Smyth; Megan A Lewis; Mark B Snowden; Corina R Ronneberg; Leanne M Williams; Ben S Gerber; Olusola A Ajilore; Aashutos S Patel; Jun Ma
Journal:  Ann Behav Med       Date:  2021-11-18

10.  Measuring social processes regarding eating, physical activity, and weight in higher-weight people: the weight-related interactions scale (WRIS).

Authors:  Elizabeth Rieger; Yee Fong Lee; Conal Monaghan; Kristy Zwickert; Kristen Murray
Journal:  Eat Weight Disord       Date:  2021-05-26       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.